Perrigo | Bienes



Assets Cambio Fecha
AbbVie USD 135.16B 8.26B 2024-12
Abbott USD 81.41B 7.06B 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Corcept Therapeutics USD 840.55M 56.3M 2024-12
Dr.Reddys Laboratories INR 481.06B 13.78B 2024-12
Eli Lilly USD 78.71B 3.11B 2024-12
J&J USD 180.1B 1.82B 2024-12
Merck USD 117.11B 426M 2024-12
Nestle CHF 139.26B 3.66B 2024-12
Pacira USD 1.55B 31.82M 2024-12
Perrigo USD 9.65B 1.56B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Prestige Brands USD 3.33B 12.61M 2024-12
Reckitt Benckiser GBP 25.3B 1.11B 2024-12
Sanofi 129.76B 3.29B 2024-06
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
Teva Pharmaceutical Industries USD 39.33B 2.43B 2024-12
Xeris Pharmaceuticals USD 323.06M 1.96M 2024-12
Zoetis USD 14.24B 120M 2024-12



Perrigo Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.